Related Experiment Video
Updated: Dec 20, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
Lisa Dannenberg1, Dorothee Zikeli1, Marcel Benkhoff1
1Department of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty of the Heinrich Heine University Düsseldorf, Cardiovascular Research Institute Düsseldorf (CARID), Düsseldorf, Germany.
Abstract:
The human gut microbiota is the most important active part of the intestinal micro-ecosystem. Lifestyle modification, drug intake and nutrition have an impact on the composition of the gut microbiota and its metabolites. This review focuses on the effects of changes in the gut microbiota as well as the important metabolite Trimethylamine-N-oxide (TMAO). Furthermore, relevant therapeutic options to target the human microbiome in patients with cardiovascular disease are presented.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Therapeutic Drug Monitoring: Affecting Factors
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
What is Monogastric Digestion?
Coronary Artery Disease IV: Preventive Measures

